Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Thorax ; 72(5): 437-444, 2017 05.
Artigo em Inglês | MEDLINE | ID: mdl-27852952

RESUMO

BACKGROUND: Obesity hypoventilation syndrome (OHS) is the most common indication for home ventilation, although the optimal therapy remains unclear, particularly for severe disease. We compared Bi-level and continuous positive airways pressure (Bi-level positive airway pressure (PAP); CPAP) for treatment of severe OHS. METHODS: We conducted a multicentre, parallel, double-blind trial for initial treatment of OHS, with participants randomised to nocturnal Bi-level PAP or CPAP for 3 months. The primary outcome was frequency of treatment failure (hospital admission, persistent ventilatory failure or non-adherence); secondary outcomes included health-related quality of life (HRQoL) and sleepiness. RESULTS: Sixty participants were randomised; 57 completed follow-up and were included in analysis (mean age 53 years, body mass index 55 kg/m2, PaCO2 60 mm Hg). There was no difference in treatment failure between groups (Bi-level PAP, 14.8% vs CPAP, 13.3%, p=0.87). Treatment adherence and wake PaCO2 were similar after 3 months (5.3 hours/night Bi-level PAP, 5.0 hours/night CPAP, p=0.62; PaCO2 44.2 and 45.9 mm Hg, respectively, p=0.60). Between-group differences in improvement in sleepiness (Epworth Sleepiness Scale 0.3 (95% CI -2.8, 3.4), p=0.86) and HRQoL (Short Form (SF)36-SF6d 0.025 (95% CI -0.039, 0.088), p=0.45) were not significant. Baseline severity of ventilatory failure (PaCO2) was the only significant predictor of persistent ventilatory failure at 3 months (OR 2.3, p=0.03). CONCLUSIONS: In newly diagnosed severe OHS, Bi-level PAP and CPAP resulted in similar improvements in ventilatory failure, HRQoL and adherence. Baseline PaCO2 predicted persistent ventilatory failure on treatment. Long-term studies are required to determine whether these treatments have different cost-effectiveness or impact on mortality. TRIAL REGISTRATION NUMBER: ACTRN12611000874910, results.


Assuntos
Pressão Positiva Contínua nas Vias Aéreas , Ventilação não Invasiva/métodos , Síndrome de Hipoventilação por Obesidade/terapia , Índice de Massa Corporal , Método Duplo-Cego , Determinação de Ponto Final , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Síndrome de Hipoventilação por Obesidade/fisiopatologia , Cooperação do Paciente , Qualidade de Vida , Testes de Função Respiratória , Fatores de Risco , Índice de Gravidade de Doença , Inquéritos e Questionários , Resultado do Tratamento
2.
Thorax ; 69(4): 346-53, 2014 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-24253834

RESUMO

INTRODUCTION: In people with obesity hypoventilation syndrome (OHS), breathing 100% oxygen increases carbon dioxide (PCO2), but its effect on pH is unknown. This study investigated the effects of moderate concentrations of supplemental oxygen on PCO2, pH, minute ventilation (VE) and physiological dead space to tidal volume ratio (VD/VT) among people with stable untreated OHS, with comparison to healthy controls. METHODS: In a double-blind randomised crossover study, participants breathed oxygen concentrations (FiO2) 0.28 and 0.50, each for 20 min, separated by a 45 min washout period. Arterialised-venous PCO2 (PavCO2) and pH, VE and VD/VT were measured at baseline, then every 5 min. Data were analysed using general linear model analysis. RESULTS: 28 participants were recruited (14 OHS, 14 controls). Among OHS participants (mean ± SD arterial PCO2 6.7 ± 0.5 kPa; arterial oxygen 8.9 ± 1.4 kPa) FiO2 0.28 and 0.50 maintained oxygen saturation 98-100%. After 20 min of FiO2 0.28, PavCO2 change (ΔPavCO2) was 0.3 ± 0.2 kPa (p = 0.013), with minimal change in VE and rises in VD/VT of 1 ± 5% (p = 0.012). FiO2 0.50 increased PavCO2 by 0.5 ± 0.4 kPa (p = 0.012), induced acidaemia and increased VD/VT by 3 ± 3% (p = 0.012). VE fell by 1.2 ± 2.1 L/min within 5 min then recovered individually to varying degrees. A negative correlation between ΔVE and ΔPavCO2 (r = -0.60, p = 0.024) suggested that ventilatory responses were the key determinant of PavCO2 rises. Among controls, FiO2 0.28 and 0.50 did not change PavCO2 or pH, but FiO2 0.50 significantly increased VE and VD/VT. CONCLUSION: Commonly used oxygen concentrations caused hypoventilation, PavCO2 rises and acidaemia among people with stable OHS. This highlights the potential dangers of this common intervention in this group.


Assuntos
Dióxido de Carbono/sangue , Hipercapnia/fisiopatologia , Síndrome de Hipoventilação por Obesidade/terapia , Oxigênio/administração & dosagem , Adulto , Gasometria , Estudos Cross-Over , Método Duplo-Cego , Feminino , Humanos , Concentração de Íons de Hidrogênio , Masculino , Pessoa de Meia-Idade , Síndrome de Hipoventilação por Obesidade/fisiopatologia , Volume de Ventilação Pulmonar/fisiologia
3.
Obstet Gynecol Int ; 2009: 942301, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19960049

RESUMO

We present a combined obstetric and respiratory perspective on two pregnancies for a woman with severe Type 2 Spinal Muscular Atrophy (SMA). Our patient had the lowest prepregnancy weight (20 kg) and vital capacity of 0.34 L (VC 11% predicted) yet to be reported in the sparse literature on pregnancy with SMA. She delivered two live healthy infants via planned caesarean section without pregnancy or neonatal complication. We describe the respiratory and obstetric management techniques used for a pregnancy with this degree of respiratory compromise.

4.
Respirology ; 14(2): 251-9, 2009 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-19210652

RESUMO

BACKGROUND AND OBJECTIVE: People with chronic hypercapnic respiratory failure (HRF) often have a ventilatory limitation to exercise with difficulty performing activities of daily living. Although non-invasive ventilation (NIV) appears to reduce the ventilatory limitation and improve exercise performance in people with severe COPD, the effect of NIV during functional activities such as unsupported arm exercise (UAE) and ground walking in people with chronic HRF is unclear. METHODS: Seventeen patients with chronic HRF (PaCO(2) 52.1 +/- 5.3 mm Hg) performed a series of UAE tests, and 15 patients (PaCO(2) 51.7 +/- 3.8 mm Hg) performed a series of endurance shuttle walk tests, with and without NIV in a randomized cross-over design. RESULTS: NIV during UAE increased endurance time by a mean of 91 s (95% confidence interval (CI): 10-172, P = 0.031) and reduced dyspnoea by a mean of 2.3 on the Borg scale (95% CI: 1.0-3.7, P = 0.002) compared with exercise without NIV. There was a non-significant increase in walking endurance time with NIV during exercise (119 s, 95% CI: -17 to 254, P = 0.081); however, isotime dyspnoea was unchanged compared with walking without NIV (-1.0, 95% CI: -3.0 to 1.0, P = 0.29). CONCLUSION: NIV during UAE increased endurance time and reduced dyspnoea compared with exercise without NIV in patients with chronic HRF. Investigation of the role of NIV as an adjunct to UAE training is warranted. In contrast, NIV during ground walking did not improve exercise capacity. However, the pressure support provided may have been inadequate as dyspnoea was not reduced.


Assuntos
Exercício Físico/fisiologia , Hipercapnia/fisiopatologia , Hipercapnia/terapia , Respiração com Pressão Positiva/métodos , Insuficiência Respiratória/fisiopatologia , Insuficiência Respiratória/terapia , Caminhada/fisiologia , Idoso , Doença Crônica , Estudos Cross-Over , Dispneia/etiologia , Dispneia/prevenção & controle , Teste de Esforço , Tolerância ao Exercício/fisiologia , Feminino , Humanos , Hipercapnia/complicações , Masculino , Pessoa de Meia-Idade , Avaliação de Resultados em Cuidados de Saúde , Doença Pulmonar Obstrutiva Crônica/complicações , Doença Pulmonar Obstrutiva Crônica/fisiopatologia , Insuficiência Respiratória/complicações
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...